Johannes P.T.M. Van Leeuwen

Prof. Dr. Johannes P.T.M. Van Leeuwen

orcid

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2004 in Bone
Verified
Journal Article
Closed access
SSS.C.E Schuit
S.C.E Schuit
MKM van der Klift
M van der Klift
AWA.E.A.M Weel
A.E.A.M Weel
CLC.E.D.H de Laet
C.E.D.H de Laet
HBH Burger
H Burger
HPH.A.P Pols
H.A.P Pols

1 September 2004 in Gene
Verified
Journal Article
Closed access
AUAndré G. Uitterlinden
André G. Uitterlinden
YFYue Fang
Yue Fang
JMJoyce B.J. van Meurs
Joyce B.J. van Meurs
HPHuibert A.P. Pols
Huibert A.P. Pols
JLJohannes P.T.M. Van Leeuwen
Johannes P.T.M. Van Leeuwen

13 May 2004 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
JMJoyce B.J. van Meurs
Joyce B.J. van Meurs
RDRosalie Dhonukshe-Rutten
Rosalie Dhonukshe-Rutten
SPSaskia M.F. Pluijm
Saskia M.F. Pluijm
MKMarjolein van der Klift
Marjolein van der Klift
RJRobert de Jonge
Robert de Jonge
AUAndré G. Uitterlinden
André G. Uitterlinden
Very high plasma homocysteine levels are characteristic of homocystinuria, a rare autosomal recessive disease accompanied by the early onset of generalized osteoporosis. We therefore hypothesized that mildly elevated homocysteine levels might be related to age-related osteoporotic fractures. We studied the association between circulating homocysteine levels and the risk of incident osteoporotic fracture in 2406 subjects, 55 years of age or older, who participated in two separate prospective, population-based studies. In the Rotterdam Study, there were two independent cohorts: 562 subjects in cohort 1, with a mean follow-up period of 8.1 years; and 553 subjects in cohort 2, with a mean follow-up period of 5.7 years. In the Longitudinal Aging Study Amsterdam, there was a single cohort of 1291 subjects, with a mean follow-up period of 2.7 years. Multivariate Cox proportional-hazards regression models were used for analysis of the risk of fracture, with adjustment for age, sex, body-mass index, and other characteristics that may be associated with the risk of fracture or with increased homocysteine levels. During 11,253 person-years of follow-up, osteoporotic fractures occurred in 191 subjects. The overall multivariable-adjusted relative risk of fracture was 1.4 (95 percent confidence interval, 1.2 to 1.6) for each increase of 1 SD in the natural-log–transformed homocysteine level. The risk was similar in all three cohorts studied, and it was also similar in men and women. A homocysteine level in the highest age-specific quartile was associated with an increase by a factor of 1.9 in the risk of fracture (95 percent confidence interval, 1.4 to 2.6). The associations between homocysteine levels and the risk of fracture appeared to be independent of bone mineral density and other potential risk factors for fracture. An increased homocysteine level appears to be a strong and independent risk factor for osteoporotic fractures in older men and women.

1 April 2012 in Biomaterials
Verified
Journal Article
Closed access
ABAna Barradas
Ana Barradas
Hugo FernandesHugo Fernandes
Hugo Fernandes
NGNathalie Groen
Nathalie Groen
YCYoke Chin Chai
Yoke Chin Chai
JSJan Schrooten
Jan Schrooten
JBJan de Boer
Jan de Boer

15 May 2013 in Diabetes Care
Verified
Journal Article
Open access
LOLing Oei
Ling Oei
MZM. Carola Zillikens
M. Carola Zillikens
ADAbbas Dehghan
Abbas Dehghan
GBGabriëlle H.S. Buitendijk
Gabriëlle H.S. Buitendijk
MCMartha C. Castaño-Betancourt
Martha C. Castaño-Betancourt
FRFernando Rivadeneira
Fernando Rivadeneira
OBJECTIVE: Individuals with type 2 diabetes have increased fracture risk despite higher bone mineral density (BMD). Our aim was to examine the influence of glucose control on skeletal complications. RESEARCH DESIGN AND METHODS: Data of 4,135 participants of the Rotterdam Study, a prospective population-based cohort, were available (mean follow-up 12.2 years). At baseline, 420 participants with type 2 diabetes were classified by glucose control (according to HbA1c calculated from fructosamine), resulting in three comparison groups: adequately controlled diabetes (ACD; n = 203; HbA1c <7.5%), inadequately controlled diabetes (ICD; n = 217; HbA1c ≥7.5%), and no diabetes (n = 3,715). Models adjusted for sex, age, height, and weight (and femoral neck BMD) were used to test for differences in bone parameters and fracture risk (hazard ratio [HR] [95% CI]). RESULTS: The ICD group had 1.1–5.6% higher BMD, 4.6–5.6% thicker cortices, and −1.2 to −1.8% narrower femoral necks than ACD and ND, respectively. Participants with ICD had 47–62% higher fracture risk than individuals without diabetes (HR 1.47 [1.12–1.92]) and ACD (1.62 [1.09–2.40]), whereas those with ACD had a risk similar to those without diabetes (0.91 [0.67–1.23]). CONCLUSIONS: Poor glycemic control in type 2 diabetes is associated with fracture risk, high BMD, and thicker femoral cortices in narrower bones. We postulate that fragility in apparently “strong” bones in ICD can result from microcrack accumulation and/or cortical porosity, reflecting impaired bone repair.

1 November 2016 in Cell Stem Cell
Verified
Journal Article
Closed access
NZNoemi A. Zambetti
Noemi A. Zambetti
ZPZhen Ping
Zhen Ping
SCSi Chen
Si Chen
KKKeane J.G. Kenswil
Keane J.G. Kenswil
MMMaria A. Mylona
Maria A. Mylona
MRMarc H.G.P. Raaijmakers
Marc H.G.P. Raaijmakers